The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
AGIOS PHARMACEUTICALS INC | COM | 00847X104 | 11,696,000 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | |||
ALPINE IMMUNE SCIENCES INC | COM | 02083G100 | 84,082,901 | 2,121,163 | SH | SOLE | 2,121,163 | 0 | 0 | |||
APOGEE THERAPEUTICS INC | COM | 03770N101 | 21,928,500 | 330,000 | SH | SOLE | 330,000 | 0 | 0 | |||
ARCELLX INC | COMMON STOCK | 03940C100 | 265,548,507 | 3,818,095 | SH | SOLE | 3,818,095 | 0 | 0 | |||
ARGENX SE | SPONSORED ADR | 04016X101 | 217,380,686 | 552,120 | SH | SOLE | 552,120 | 0 | 0 | |||
ARVINAS INC | COM | 04335A105 | 107,944,517 | 2,614,935 | SH | SOLE | 2,614,935 | 0 | 0 | |||
ASCENDIS PHARMA A/S | SPONSORED ADR | 04351P101 | 76,787,104 | 507,952 | SH | SOLE | 507,952 | 0 | 0 | |||
AUTOLUS THERAPEUTICS PLC | SPON ADS | 05280R100 | 40,996,623 | 6,425,803 | SH | SOLE | 6,425,803 | 0 | 0 | |||
BICYCLE THERAPEUTICS PLC | SPONSORED ADS | 088786108 | 80,844,299 | 3,246,759 | SH | SOLE | 3,246,759 | 0 | 0 | |||
CARGO THERAPEUTICS INC | COM | 14179K101 | 3,302,445 | 147,959 | SH | SOLE | 147,959 | 0 | 0 | |||
CARIBOU BIOSCIENCES INC | COM | 142038108 | 11,167,267 | 2,172,620 | SH | SOLE | 2,172,620 | 0 | 0 | |||
CEREVEL THERAPEUTICS HLDNG I | COM | 15678U128 | 98,510,573 | 2,330,508 | SH | SOLE | 2,330,508 | 0 | 0 | |||
COMPASS PATHWAYS PLC | SPONSORED ADS | 20451W101 | 19,893,020 | 2,390,988 | SH | SOLE | 2,390,988 | 0 | 0 | |||
CRINETICS PHARMACEUTICALS IN | COM | 22663K107 | 146,269,500 | 3,124,749 | SH | SOLE | 3,124,749 | 0 | 0 | |||
CULLINAN ONCOLOGY INC | COM | 230031106 | 22,970,176 | 1,348,015 | SH | SOLE | 1,348,015 | 0 | 0 | |||
DISC MEDICINE INC | COM | 254604101 | 148,795,299 | 2,389,902 | SH | SOLE | 2,389,902 | 0 | 0 | |||
EDGEWISE THERAPEUTICS INC | COM | 28036F105 | 44,621,844 | 2,446,373 | SH | SOLE | 2,446,373 | 0 | 0 | |||
IMMATICS N.V | SHS | N44445109 | 29,626,723 | 2,818,908 | SH | SOLE | 2,818,908 | 0 | 0 | |||
IMMUNOCORE HLDGS PLC | ADS | 45258D105 | 116,166,440 | 1,787,176 | SH | SOLE | 1,787,176 | 0 | 0 | |||
IMMUNOVANT INC | COM | 45258J102 | 25,817,435 | 799,054 | SH | SOLE | 799,054 | 0 | 0 | |||
KURA ONCOLOGY INC | COM | 50127T109 | 66,877,805 | 3,135,387 | SH | SOLE | 3,135,387 | 0 | 0 | |||
KYVERNA THERAPEUTICS INC | COM | 501976104 | 1,242,000 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | |||
LEGEND BIOTECH CORP | SPONSORED ADS | 52490G102 | 111,170,717 | 1,982,006 | SH | SOLE | 1,982,006 | 0 | 0 | |||
NUVALENT INC | COM | 670703107 | 313,713,255 | 4,177,830 | SH | SOLE | 4,177,830 | 0 | 0 | |||
OLEMA PHARMACEUTICALS INC | COM | 68062P106 | 89,468,752 | 7,903,600 | SH | SOLE | 7,903,600 | 0 | 0 | |||
REVOLUTION MEDICINES INC | COM | 76155X100 | 93,949,644 | 2,914,975 | SH | SOLE | 2,914,975 | 0 | 0 | |||
SAREPTA THERAPEUTICS INC | COM | 803607100 | 139,602,673 | 1,078,346 | SH | SOLE | 1,078,346 | 0 | 0 | |||
TARSUS PHARMACEUTICALS INC | COM | 87650L103 | 104,084,808 | 2,863,406 | SH | SOLE | 2,863,406 | 0 | 0 | |||
VAXCYTE INC | COM | 92243G108 | 84,704,058 | 1,239,995 | SH | SOLE | 1,239,995 | 0 | 0 | |||
VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | 88,100,164 | 5,031,420 | SH | SOLE | 5,031,420 | 0 | 0 | |||
VOR BIOPHARMA INC | COM | 929033108 | 15,303,784 | 6,457,293 | SH | SOLE | 6,457,293 | 0 | 0 | |||
XENON PHARMACEUTICALS INC | COM | 98420N105 | 106,973,826 | 2,484,874 | SH | SOLE | 2,484,874 | 0 | 0 | |||
Y-MABS THERAPEUTICS INC | COM | 984241109 | 36,318,499 | 2,233,610 | SH | SOLE | 2,233,610 | 0 | 0 | |||
ZENTALIS PHARMACEUTICALS INC | COM | 98943L107 | 14,891,892 | 944,917 | SH | SOLE | 944,917 | 0 | 0 |